These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16338879)

  • 41. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella.
    Ramet J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S49-55. PubMed ID: 18162247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
    Halperin SA; Ferrera G; Scheifele D; Predy G; Stella G; Cuccia M; Douha M; Willems P
    Vaccine; 2009 May; 27(20):2701-6. PubMed ID: 19428882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute infections, infection pressure, and atopy.
    Paunio M; Peltola H; Virtanen M; Leinikki P; Makela A; Heinonen OP
    Clin Exp Allergy; 2006 May; 36(5):634-9. PubMed ID: 16650049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chickenpox: sufficient reasons for the introduction of vaccination].
    Rümke H; de Groot R
    Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2630-2. PubMed ID: 17205937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.
    France EK; Glanz J; Xu S; Hambidge S; Yamasaki K; Black SB; Marcy M; Mullooly JP; Jackson LA; Nordin J; Belongia EA; Hohman K; Chen RT; Davis R;
    Pediatrics; 2008 Mar; 121(3):e687-92. PubMed ID: 18310189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
    Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing the introduction of universal varicella vaccination in the Netherlands.
    Boot HJ; de Melker HE; Stolk EA; de Wit GA; Kimman TG
    Vaccine; 2006 Sep; 24(37-39):6288-99. PubMed ID: 16790302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Infectious diseases of childhood and their anesthetic implications.
    van der Walt JH; Jacob R; Zoanetti DC
    Paediatr Anaesth; 2004 Oct; 14(10):810-9. PubMed ID: 15385008
    [No Abstract]   [Full Text] [Related]  

  • 49. Epidemiology of hospital admissions for chickenpox in children: an Italian multicentre study in the pre-vaccine era.
    Marchetto S; de Benedictis FM; de Martino M; Versace A; Chiappini E; Bertaine C; Osimani P; Cordiali R; Gabiano C; Galli L
    Acta Paediatr; 2007 Oct; 96(10):1490-3. PubMed ID: 17880417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Jan; 27(1):63-9. PubMed ID: 16432596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants.
    Yerkovich ST; Rowe J; Richmond P; Suriyaarachchi D; Heaton T; Hollams E; Ladyman C; Serralha M; Sadowska A; Loh R; Wesselingh SL; Sly PD; Holt PG
    Vaccine; 2007 Feb; 25(10):1764-70. PubMed ID: 17224218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relations between epidemic parotitis and diabetes mellitus].
    Baratono S; Visconti A
    G Mal Infett Parassit; 1968 Feb; 20(2):197-200. PubMed ID: 5741088
    [No Abstract]   [Full Text] [Related]  

  • 54. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
    Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D
    Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoprophylaxis with gamma globulin.
    Weichsel M
    Proc Rudolf Virchow Med Soc City N Y; 1967; 26():117-26. PubMed ID: 4190595
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapy of common exanthematous diseases].
    COLARIZI A
    Rass Medica; 1953 Jun; 30(6):99-107. PubMed ID: 13100718
    [No Abstract]   [Full Text] [Related]  

  • 58. [Association of viral hepatitis and exanthematic diseases. Report of 5 cases. Clinical and laboratory studies].
    Cantalini C; Marimpietri A
    Minerva Pediatr; 1972 Mar; 24(7):259-65. PubMed ID: 5012840
    [No Abstract]   [Full Text] [Related]  

  • 59. ABC of 1 to 7. Common rashes.
    Valman HB
    Br Med J (Clin Res Ed); 1981 Oct; 283(6297):970-1. PubMed ID: 6793197
    [No Abstract]   [Full Text] [Related]  

  • 60. Risk of serious neurologic disease after immunization of young children in Britain and Ireland.
    Ward KN; Bryant NJ; Andrews NJ; Bowley JS; Ohrling A; Verity CM; Ross EM; Miller E
    Pediatrics; 2007 Aug; 120(2):314-21. PubMed ID: 17671057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.